SHCSotera Health Co

Nasdaq soterahealth.com


$ 16.64 $ -0.22 (-1.28 %)    

Tuesday, 17-Sep-2024 15:55:47 EDT
QQQ $ 473.37 $ -2.60 (-0.55 %)
DIA $ 417.24 $ -0.75 (-0.18 %)
SPY $ 562.96 $ -2.17 (-0.38 %)
TLT $ 100.79 $ -0.60 (-0.59 %)
GLD $ 237.37 $ -0.61 (-0.26 %)
$ 16.91
$ 16.85
$ 16.63 x 100
$ 16.64 x 600
$ 16.51 - $ 16.98
$ 10.71 - $ 17.44
1,165,137
na
4.79B
$ 1.79
$ 119.44
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-09-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-sotera-health-shc-stock

Sotera Health shares are trading higher by 5.5% during Thursday's session. The company late Wednesday announced a secondary...

 sotera-health-reports-launch-of-secondary-offering-of-25m-shares-by-certain-affiliates-of-warburg-pincus-and-gtcr

It is expected that, as a result of the Offering, the Company's sponsors (affiliates of Warburg Pincus and GTCR) will cease...

 barclays-maintains-overweight-on-sotera-health-raises-price-target-to-17

Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $14 to...

 rbc-capital-reiterates-outperform-on-sotera-health-maintains-17-price-target

RBC Capital analyst Sean Dodge reiterates Sotera Health (NASDAQ:SHC) with a Outperform and maintains $17 price target.

 sotera-health-co-reiterated-fy24-net-revenue-growth-of-4-6-vs-110b-est-adj-eps-of-067-075-vs-072-est

2024 Outlook Today, Sotera Health is reaffirming the 2024 outlook previously provided. As a reminder, the outlook is: Net r...

 expert-ratings-for-sotera-health
Expert Ratings For Sotera Health
05/21/2024 12:01:06

 piper-sandler-initiates-coverage-on-sotera-health-with-neutral-rating-announces-price-target-of-13

Piper Sandler analyst Jason Bednar initiates coverage on Sotera Health (NASDAQ:SHC) with a Neutral rating and announces Pric...

 sotera-health-q1-2024-adj-eps-013-beats-012-estimate-sales-248176m-beat-244350m-estimate

Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by...

 barclays-maintains-overweight-on-sotera-health-lowers-price-target-to-14

Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $19 to...

 citigroup-upgrades-sotera-health-to-buy-lowers-price-target-to-16

Citigroup analyst Patrick Donnelly upgrades Sotera Health (NASDAQ:SHC) from Neutral to Buy and lowers the price target from ...

 jefferies-upgrades-sotera-health-to-buy-raises-price-target-to-155

Jefferies analyst David Windley upgrades Sotera Health (NASDAQ:SHC) from Hold to Buy and raises the price target from $15 to...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION